

# Table of Contents

 * [1 Sensitivity Analysis ](#sensitivity-analysis)
   * [1.1 Sensitivity Analysis for Raltegravir 10 mg (lactose formulation) ](#sensitivity-analysis-raltegravir_10_mg__lactose_formulation_)
   * [1.2 Sensitivity Analysis for Raltegravir 100 mg filmcoated tablet md ](#sensitivity-analysis-raltegravir_100_mg_filmcoated_tablet_md)
   * [1.3 Sensitivity Analysis for Raltegravir 200 mg filmcoated tablet md ](#sensitivity-analysis-raltegravir_200_mg_filmcoated_tablet_md)
   * [1.4 Sensitivity Analysis for Filmcoated_tablet_400mg_sd ](#sensitivity-analysis-filmcoated_tablet_400mg_sd)
   * [1.5 Sensitivity Analysis for Raltegravir 400 mg filmcoated tablet md ](#sensitivity-analysis-raltegravir_400_mg_filmcoated_tablet_md)
   * [1.6 Sensitivity Analysis for Raltegravir 400mg chewable fasted ](#sensitivity-analysis-raltegravir_400mg_chewable_fasted)
   * [1.7 Sensitivity Analysis for Raltegravir 400mg chewable fed ](#sensitivity-analysis-raltegravir_400mg_chewable_fed)
   * [1.8 Sensitivity Analysis for Raltegravir 400mg (granules in suspension) ](#sensitivity-analysis-raltegravir_400mg__granules_in_suspension_)
 * [2 PK parameters ](#pk-parameters)
   * [2.1 PK parameters for Raltegravir 10 mg (lactose formulation) ](#pk-parameters-raltegravir_10_mg__lactose_formulation_)
   * [2.2 PK parameters for Raltegravir 100 mg filmcoated tablet md ](#pk-parameters-raltegravir_100_mg_filmcoated_tablet_md)
   * [2.3 PK parameters for Raltegravir 200 mg filmcoated tablet md ](#pk-parameters-raltegravir_200_mg_filmcoated_tablet_md)
   * [2.4 PK parameters for Filmcoated_tablet_400mg_sd ](#pk-parameters-filmcoated_tablet_400mg_sd)
   * [2.5 PK parameters for Raltegravir 400 mg filmcoated tablet md ](#pk-parameters-raltegravir_400_mg_filmcoated_tablet_md)
   * [2.6 PK parameters for Raltegravir 400mg chewable fasted ](#pk-parameters-raltegravir_400mg_chewable_fasted)
   * [2.7 PK parameters for Raltegravir 400mg chewable fed ](#pk-parameters-raltegravir_400mg_chewable_fed)
   * [2.8 PK parameters for Raltegravir 400mg (granules in suspension) ](#pk-parameters-raltegravir_400mg__granules_in_suspension_)
 * [3 Absorption ](#absorption)
   * [3.1 Absorption for Raltegravir 10 mg (lactose formulation) ](#absorption-raltegravir_10_mg__lactose_formulation_)
   * [3.2 Absorption for Raltegravir 100 mg filmcoated tablet md ](#absorption-raltegravir_100_mg_filmcoated_tablet_md)
   * [3.3 Absorption for Raltegravir 200 mg filmcoated tablet md ](#absorption-raltegravir_200_mg_filmcoated_tablet_md)
   * [3.4 Absorption for Filmcoated_tablet_400mg_sd ](#absorption-filmcoated_tablet_400mg_sd)
   * [3.5 Absorption for Raltegravir 400 mg filmcoated tablet md ](#absorption-raltegravir_400_mg_filmcoated_tablet_md)
   * [3.6 Absorption for Raltegravir 400mg chewable fasted ](#absorption-raltegravir_400mg_chewable_fasted)
   * [3.7 Absorption for Raltegravir 400mg chewable fed ](#absorption-raltegravir_400mg_chewable_fed)
   * [3.8 Absorption for Raltegravir 400mg (granules in suspension) ](#absorption-raltegravir_400mg__granules_in_suspension_)
 * [4 Mass Balance ](#mass-balance)
   * [4.1 Mass Balance for Raltegravir 10 mg (lactose formulation) ](#mass-balance-raltegravir_10_mg__lactose_formulation_)
     * [4.1.1 Mass Balance for Raltegravir ](#1_mass_balance)
   * [4.2 Mass Balance for Raltegravir 100 mg filmcoated tablet md ](#mass-balance-raltegravir_100_mg_filmcoated_tablet_md)
     * [4.2.1 Mass Balance for Raltegravir ](#1_mass_balance)
   * [4.3 Mass Balance for Raltegravir 200 mg filmcoated tablet md ](#mass-balance-raltegravir_200_mg_filmcoated_tablet_md)
     * [4.3.1 Mass Balance for Raltegravir ](#1_mass_balance)
   * [4.4 Mass Balance for Filmcoated_tablet_400mg_sd ](#mass-balance-filmcoated_tablet_400mg_sd)
     * [4.4.1 Mass Balance for Raltegravir ](#1_mass_balance)
   * [4.5 Mass Balance for Raltegravir 400 mg filmcoated tablet md ](#mass-balance-raltegravir_400_mg_filmcoated_tablet_md)
     * [4.5.1 Mass Balance for Raltegravir ](#1_mass_balance)
   * [4.6 Mass Balance for Raltegravir 400mg chewable fasted ](#mass-balance-raltegravir_400mg_chewable_fasted)
     * [4.6.1 Mass Balance for Raltegravir ](#1_mass_balance)
   * [4.7 Mass Balance for Raltegravir 400mg chewable fed ](#mass-balance-raltegravir_400mg_chewable_fed)
     * [4.7.1 Mass Balance for Raltegravir ](#1_mass_balance)
   * [4.8 Mass Balance for Raltegravir 400mg (granules in suspension) ](#mass-balance-raltegravir_400mg__granules_in_suspension_)
     * [4.8.1 Mass Balance for Raltegravir ](#1_mass_balance)
 * [5 Time profiles and residual plots ](#time-profiles)
   * [5.1 Time profiles and residual plots for Raltegravir 10 mg (lactose formulation) ](#time-profiles-raltegravir_10_mg__lactose_formulation_)
   * [5.2 Time profiles and residual plots for Raltegravir 100 mg filmcoated tablet md ](#time-profiles-raltegravir_100_mg_filmcoated_tablet_md)
     * [5.2.1 For total simulation time range ](#goodness-of-fit-raltegravir_100_mg_filmcoated_tablet_md-total)
     * [5.2.2 For first application range ](#goodness-of-fit-raltegravir_100_mg_filmcoated_tablet_md-first)
     * [5.2.3 For last application range ](#goodness-of-fit-raltegravir_100_mg_filmcoated_tablet_md-last)
   * [5.3 Time profiles and residual plots for Raltegravir 200 mg filmcoated tablet md ](#time-profiles-raltegravir_200_mg_filmcoated_tablet_md)
     * [5.3.1 For total simulation time range ](#goodness-of-fit-raltegravir_200_mg_filmcoated_tablet_md-total)
     * [5.3.2 For first application range ](#goodness-of-fit-raltegravir_200_mg_filmcoated_tablet_md-first)
     * [5.3.3 For last application range ](#goodness-of-fit-raltegravir_200_mg_filmcoated_tablet_md-last)
   * [5.4 Time profiles and residual plots for Filmcoated_tablet_400mg_sd ](#time-profiles-filmcoated_tablet_400mg_sd)
   * [5.5 Time profiles and residual plots for Raltegravir 400 mg filmcoated tablet md ](#time-profiles-raltegravir_400_mg_filmcoated_tablet_md)
     * [5.5.1 For total simulation time range ](#goodness-of-fit-raltegravir_400_mg_filmcoated_tablet_md-total)
     * [5.5.2 For first application range ](#goodness-of-fit-raltegravir_400_mg_filmcoated_tablet_md-first)
     * [5.5.3 For last application range ](#goodness-of-fit-raltegravir_400_mg_filmcoated_tablet_md-last)
   * [5.6 Time profiles and residual plots for Raltegravir 400mg chewable fasted ](#time-profiles-raltegravir_400mg_chewable_fasted)
   * [5.7 Time profiles and residual plots for Raltegravir 400mg chewable fed ](#time-profiles-raltegravir_400mg_chewable_fed)
   * [5.8 Time profiles and residual plots for Raltegravir 400mg (granules in suspension) ](#time-profiles-raltegravir_400mg__granules_in_suspension_)
   * [5.9 Residuals across all simulations ](#time-profiles-residuals-across-all-simulations)





# 1 Sensitivity Analysis <a id="sensitivity-analysis"></a>


## 1.1 Sensitivity Analysis for Raltegravir 10 mg (lactose formulation) <a id="sensitivity-analysis-raltegravir_10_mg__lactose_formulation_"></a>


<a id="figure-1-1"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-1_sensitivity_C_max.png)



**Figure 1-1: Most sensitive parameters for C_max of Raltegravir.**


<br>
<br>


<a id="figure-1-2"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-2_sensitivity_t_max.png)



**Figure 1-2: Most sensitive parameters for t_max of Raltegravir.**


<br>
<br>


<a id="figure-1-3"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-3_sensitivity_C_tEnd.png)



**Figure 1-3: Most sensitive parameters for C_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-4"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-4_sensitivity_AUC_tEnd.png)



**Figure 1-4: Most sensitive parameters for AUC of Raltegravir.**


<br>
<br>


<a id="figure-1-5"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-5_sensitivity_AUC_inf.png)



**Figure 1-5: Most sensitive parameters for AUC_inf of Raltegravir.**


<br>
<br>


<a id="figure-1-6"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-6_sensitivity_MRT.png)



**Figure 1-6: Most sensitive parameters for MRT of Raltegravir.**


<br>
<br>


<a id="figure-1-7"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-7_sensitivity_Thalf.png)



**Figure 1-7: Most sensitive parameters for Thalf of Raltegravir.**


<br>
<br>


<a id="figure-1-8"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-8_sensitivity_CL.png)



**Figure 1-8: Most sensitive parameters for CL of Raltegravir.**


<br>
<br>


<a id="figure-1-9"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-9_sensitivity_Vss.png)



**Figure 1-9: Most sensitive parameters for Vss of Raltegravir.**


<br>
<br>


<a id="figure-1-10"></a>

![](Sensitivity/Raltegravir_10_mg__lactose_formulation_-10_sensitivity_Vd.png)



**Figure 1-10: Most sensitive parameters for Vd of Raltegravir.**


<br>
<br>


## 1.2 Sensitivity Analysis for Raltegravir 100 mg filmcoated tablet md <a id="sensitivity-analysis-raltegravir_100_mg_filmcoated_tablet_md"></a>


<a id="figure-1-11"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-1_sensitivity_C_max.png)



**Figure 1-11: Most sensitive parameters for C_max of Raltegravir.**


<br>
<br>


<a id="figure-1-12"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-2_sensitivity_C_max_tD1_tD2.png)



**Figure 1-12: Most sensitive parameters for C_max_t1_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-13"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-3_sensitivity_C_max_tDLast_tEnd.png)



**Figure 1-13: Most sensitive parameters for C_max_tLast_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-14"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-4_sensitivity_t_max.png)



**Figure 1-14: Most sensitive parameters for t_max of Raltegravir.**


<br>
<br>


<a id="figure-1-15"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-5_sensitivity_t_max_tD1_tD2.png)



**Figure 1-15: Most sensitive parameters for t_max_t1_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-16"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-6_sensitivity_t_max_tDLast_tEnd.png)



**Figure 1-16: Most sensitive parameters for t_max_tLast_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-17"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-7_sensitivity_C_trough_tD2.png)



**Figure 1-17: Most sensitive parameters for C_trough_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-18"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-8_sensitivity_C_trough_tDLast.png)



**Figure 1-18: Most sensitive parameters for C_trough_tLast of Raltegravir.**


<br>
<br>


<a id="figure-1-19"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-9_sensitivity_AUC_tD1_tD2.png)



**Figure 1-19: Most sensitive parameters for AUC_t1_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-20"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-10_sensitivity_AUC_tDLast_minus_1_tDLast.png)



**Figure 1-20: Most sensitive parameters for AUC_tLast_minus_1_tLast of Raltegravir.**


<br>
<br>


<a id="figure-1-21"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-11_sensitivity_AUC_inf_tD1.png)



**Figure 1-21: Most sensitive parameters for AUC_inf_t1 of Raltegravir.**


<br>
<br>


<a id="figure-1-22"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-12_sensitivity_AUC_inf_tDLast.png)



**Figure 1-22: Most sensitive parameters for AUC_inf_tLast of Raltegravir.**


<br>
<br>


<a id="figure-1-23"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-13_sensitivity_MRT.png)



**Figure 1-23: Most sensitive parameters for MRT of Raltegravir.**


<br>
<br>


<a id="figure-1-24"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-14_sensitivity_Thalf.png)



**Figure 1-24: Most sensitive parameters for Thalf of Raltegravir.**


<br>
<br>


<a id="figure-1-25"></a>

![](Sensitivity/Raltegravir_100_mg_filmcoated_tablet_md-15_sensitivity_Thalf_tDLast_tEnd.png)



**Figure 1-25: Most sensitive parameters for Thalf_tLast_tEnd of Raltegravir.**


<br>
<br>


## 1.3 Sensitivity Analysis for Raltegravir 200 mg filmcoated tablet md <a id="sensitivity-analysis-raltegravir_200_mg_filmcoated_tablet_md"></a>


<a id="figure-1-26"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-1_sensitivity_C_max.png)



**Figure 1-26: Most sensitive parameters for C_max of Raltegravir.**


<br>
<br>


<a id="figure-1-27"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-2_sensitivity_C_max_tD1_tD2.png)



**Figure 1-27: Most sensitive parameters for C_max_t1_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-28"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-3_sensitivity_C_max_tDLast_tEnd.png)



**Figure 1-28: Most sensitive parameters for C_max_tLast_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-29"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-4_sensitivity_t_max.png)



**Figure 1-29: Most sensitive parameters for t_max of Raltegravir.**


<br>
<br>


<a id="figure-1-30"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-5_sensitivity_t_max_tD1_tD2.png)



**Figure 1-30: Most sensitive parameters for t_max_t1_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-31"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-6_sensitivity_t_max_tDLast_tEnd.png)



**Figure 1-31: Most sensitive parameters for t_max_tLast_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-32"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-7_sensitivity_C_trough_tD2.png)



**Figure 1-32: Most sensitive parameters for C_trough_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-33"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-8_sensitivity_C_trough_tDLast.png)



**Figure 1-33: Most sensitive parameters for C_trough_tLast of Raltegravir.**


<br>
<br>


<a id="figure-1-34"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-9_sensitivity_AUC_tD1_tD2.png)



**Figure 1-34: Most sensitive parameters for AUC_t1_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-35"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-10_sensitivity_AUC_tDLast_minus_1_tDLast.png)



**Figure 1-35: Most sensitive parameters for AUC_tLast_minus_1_tLast of Raltegravir.**


<br>
<br>


<a id="figure-1-36"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-11_sensitivity_AUC_inf_tD1.png)



**Figure 1-36: Most sensitive parameters for AUC_inf_t1 of Raltegravir.**


<br>
<br>


<a id="figure-1-37"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-12_sensitivity_AUC_inf_tDLast.png)



**Figure 1-37: Most sensitive parameters for AUC_inf_tLast of Raltegravir.**


<br>
<br>


<a id="figure-1-38"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-13_sensitivity_MRT.png)



**Figure 1-38: Most sensitive parameters for MRT of Raltegravir.**


<br>
<br>


<a id="figure-1-39"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-14_sensitivity_Thalf.png)



**Figure 1-39: Most sensitive parameters for Thalf of Raltegravir.**


<br>
<br>


<a id="figure-1-40"></a>

![](Sensitivity/Raltegravir_200_mg_filmcoated_tablet_md-15_sensitivity_Thalf_tDLast_tEnd.png)



**Figure 1-40: Most sensitive parameters for Thalf_tLast_tEnd of Raltegravir.**


<br>
<br>


## 1.4 Sensitivity Analysis for Filmcoated_tablet_400mg_sd <a id="sensitivity-analysis-filmcoated_tablet_400mg_sd"></a>


<a id="figure-1-41"></a>

![](Sensitivity/Filmcoated_tablet_400mg_sd-1_sensitivity_C_max.png)



**Figure 1-41: Most sensitive parameters for C_max of Raltegravir.**


<br>
<br>


<a id="figure-1-42"></a>

![](Sensitivity/Filmcoated_tablet_400mg_sd-2_sensitivity_t_max.png)



**Figure 1-42: Most sensitive parameters for t_max of Raltegravir.**


<br>
<br>


<a id="figure-1-43"></a>

![](Sensitivity/Filmcoated_tablet_400mg_sd-3_sensitivity_C_tEnd.png)



**Figure 1-43: Most sensitive parameters for C_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-44"></a>

![](Sensitivity/Filmcoated_tablet_400mg_sd-4_sensitivity_AUC_tEnd.png)



**Figure 1-44: Most sensitive parameters for AUC of Raltegravir.**


<br>
<br>


<a id="figure-1-45"></a>

![](Sensitivity/Filmcoated_tablet_400mg_sd-5_sensitivity_AUC_inf.png)



**Figure 1-45: Most sensitive parameters for AUC_inf of Raltegravir.**


<br>
<br>


<a id="figure-1-46"></a>

![](Sensitivity/Filmcoated_tablet_400mg_sd-6_sensitivity_MRT.png)



**Figure 1-46: Most sensitive parameters for MRT of Raltegravir.**


<br>
<br>


<a id="figure-1-47"></a>

![](Sensitivity/Filmcoated_tablet_400mg_sd-7_sensitivity_Thalf.png)



**Figure 1-47: Most sensitive parameters for Thalf of Raltegravir.**


<br>
<br>


<a id="figure-1-48"></a>

![](Sensitivity/Filmcoated_tablet_400mg_sd-8_sensitivity_CL.png)



**Figure 1-48: Most sensitive parameters for CL of Raltegravir.**


<br>
<br>


<a id="figure-1-49"></a>

![](Sensitivity/Filmcoated_tablet_400mg_sd-9_sensitivity_Vss.png)



**Figure 1-49: Most sensitive parameters for Vss of Raltegravir.**


<br>
<br>


<a id="figure-1-50"></a>

![](Sensitivity/Filmcoated_tablet_400mg_sd-10_sensitivity_Vd.png)



**Figure 1-50: Most sensitive parameters for Vd of Raltegravir.**


<br>
<br>


## 1.5 Sensitivity Analysis for Raltegravir 400 mg filmcoated tablet md <a id="sensitivity-analysis-raltegravir_400_mg_filmcoated_tablet_md"></a>


<a id="figure-1-51"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-1_sensitivity_C_max.png)



**Figure 1-51: Most sensitive parameters for C_max of Raltegravir.**


<br>
<br>


<a id="figure-1-52"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-2_sensitivity_C_max_tD1_tD2.png)



**Figure 1-52: Most sensitive parameters for C_max_t1_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-53"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-3_sensitivity_C_max_tDLast_tEnd.png)



**Figure 1-53: Most sensitive parameters for C_max_tLast_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-54"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-4_sensitivity_t_max.png)



**Figure 1-54: Most sensitive parameters for t_max of Raltegravir.**


<br>
<br>


<a id="figure-1-55"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-5_sensitivity_t_max_tD1_tD2.png)



**Figure 1-55: Most sensitive parameters for t_max_t1_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-56"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-6_sensitivity_t_max_tDLast_tEnd.png)



**Figure 1-56: Most sensitive parameters for t_max_tLast_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-57"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-7_sensitivity_C_trough_tD2.png)



**Figure 1-57: Most sensitive parameters for C_trough_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-58"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-8_sensitivity_C_trough_tDLast.png)



**Figure 1-58: Most sensitive parameters for C_trough_tLast of Raltegravir.**


<br>
<br>


<a id="figure-1-59"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-9_sensitivity_AUC_tD1_tD2.png)



**Figure 1-59: Most sensitive parameters for AUC_t1_t2 of Raltegravir.**


<br>
<br>


<a id="figure-1-60"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-10_sensitivity_AUC_tDLast_minus_1_tDLast.png)



**Figure 1-60: Most sensitive parameters for AUC_tLast_minus_1_tLast of Raltegravir.**


<br>
<br>


<a id="figure-1-61"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-11_sensitivity_AUC_inf_tD1.png)



**Figure 1-61: Most sensitive parameters for AUC_inf_t1 of Raltegravir.**


<br>
<br>


<a id="figure-1-62"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-12_sensitivity_AUC_inf_tDLast.png)



**Figure 1-62: Most sensitive parameters for AUC_inf_tLast of Raltegravir.**


<br>
<br>


<a id="figure-1-63"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-13_sensitivity_MRT.png)



**Figure 1-63: Most sensitive parameters for MRT of Raltegravir.**


<br>
<br>


<a id="figure-1-64"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-14_sensitivity_Thalf.png)



**Figure 1-64: Most sensitive parameters for Thalf of Raltegravir.**


<br>
<br>


<a id="figure-1-65"></a>

![](Sensitivity/Raltegravir_400_mg_filmcoated_tablet_md-15_sensitivity_Thalf_tDLast_tEnd.png)



**Figure 1-65: Most sensitive parameters for Thalf_tLast_tEnd of Raltegravir.**


<br>
<br>


## 1.6 Sensitivity Analysis for Raltegravir 400mg chewable fasted <a id="sensitivity-analysis-raltegravir_400mg_chewable_fasted"></a>


<a id="figure-1-66"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fasted-1_sensitivity_C_max.png)



**Figure 1-66: Most sensitive parameters for C_max of Raltegravir.**


<br>
<br>


<a id="figure-1-67"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fasted-2_sensitivity_t_max.png)



**Figure 1-67: Most sensitive parameters for t_max of Raltegravir.**


<br>
<br>


<a id="figure-1-68"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fasted-3_sensitivity_C_tEnd.png)



**Figure 1-68: Most sensitive parameters for C_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-69"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fasted-4_sensitivity_AUC_tEnd.png)



**Figure 1-69: Most sensitive parameters for AUC of Raltegravir.**


<br>
<br>


<a id="figure-1-70"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fasted-5_sensitivity_AUC_inf.png)



**Figure 1-70: Most sensitive parameters for AUC_inf of Raltegravir.**


<br>
<br>


<a id="figure-1-71"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fasted-6_sensitivity_MRT.png)



**Figure 1-71: Most sensitive parameters for MRT of Raltegravir.**


<br>
<br>


<a id="figure-1-72"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fasted-7_sensitivity_Thalf.png)



**Figure 1-72: Most sensitive parameters for Thalf of Raltegravir.**


<br>
<br>


<a id="figure-1-73"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fasted-8_sensitivity_CL.png)



**Figure 1-73: Most sensitive parameters for CL of Raltegravir.**


<br>
<br>


<a id="figure-1-74"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fasted-9_sensitivity_Vss.png)



**Figure 1-74: Most sensitive parameters for Vss of Raltegravir.**


<br>
<br>


<a id="figure-1-75"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fasted-10_sensitivity_Vd.png)



**Figure 1-75: Most sensitive parameters for Vd of Raltegravir.**


<br>
<br>


## 1.7 Sensitivity Analysis for Raltegravir 400mg chewable fed <a id="sensitivity-analysis-raltegravir_400mg_chewable_fed"></a>


<a id="figure-1-76"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fed-1_sensitivity_C_max.png)



**Figure 1-76: Most sensitive parameters for C_max of Raltegravir.**


<br>
<br>


<a id="figure-1-77"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fed-2_sensitivity_t_max.png)



**Figure 1-77: Most sensitive parameters for t_max of Raltegravir.**


<br>
<br>


<a id="figure-1-78"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fed-3_sensitivity_C_tEnd.png)



**Figure 1-78: Most sensitive parameters for C_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-79"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fed-4_sensitivity_AUC_tEnd.png)



**Figure 1-79: Most sensitive parameters for AUC of Raltegravir.**


<br>
<br>


<a id="figure-1-80"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fed-5_sensitivity_AUC_inf.png)



**Figure 1-80: Most sensitive parameters for AUC_inf of Raltegravir.**


<br>
<br>


<a id="figure-1-81"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fed-6_sensitivity_MRT.png)



**Figure 1-81: Most sensitive parameters for MRT of Raltegravir.**


<br>
<br>


<a id="figure-1-82"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fed-7_sensitivity_Thalf.png)



**Figure 1-82: Most sensitive parameters for Thalf of Raltegravir.**


<br>
<br>


<a id="figure-1-83"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fed-8_sensitivity_CL.png)



**Figure 1-83: Most sensitive parameters for CL of Raltegravir.**


<br>
<br>


<a id="figure-1-84"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fed-9_sensitivity_Vss.png)



**Figure 1-84: Most sensitive parameters for Vss of Raltegravir.**


<br>
<br>


<a id="figure-1-85"></a>

![](Sensitivity/Raltegravir_400mg_chewable_fed-10_sensitivity_Vd.png)



**Figure 1-85: Most sensitive parameters for Vd of Raltegravir.**


<br>
<br>


## 1.8 Sensitivity Analysis for Raltegravir 400mg (granules in suspension) <a id="sensitivity-analysis-raltegravir_400mg__granules_in_suspension_"></a>


<a id="figure-1-86"></a>

![](Sensitivity/Raltegravir_400mg__granules_in_suspension_-1_sensitivity_C_max.png)



**Figure 1-86: Most sensitive parameters for C_max of Raltegravir.**


<br>
<br>


<a id="figure-1-87"></a>

![](Sensitivity/Raltegravir_400mg__granules_in_suspension_-2_sensitivity_t_max.png)



**Figure 1-87: Most sensitive parameters for t_max of Raltegravir.**


<br>
<br>


<a id="figure-1-88"></a>

![](Sensitivity/Raltegravir_400mg__granules_in_suspension_-3_sensitivity_C_tEnd.png)



**Figure 1-88: Most sensitive parameters for C_tEnd of Raltegravir.**


<br>
<br>


<a id="figure-1-89"></a>

![](Sensitivity/Raltegravir_400mg__granules_in_suspension_-4_sensitivity_AUC_tEnd.png)



**Figure 1-89: Most sensitive parameters for AUC of Raltegravir.**


<br>
<br>


<a id="figure-1-90"></a>

![](Sensitivity/Raltegravir_400mg__granules_in_suspension_-5_sensitivity_AUC_inf.png)



**Figure 1-90: Most sensitive parameters for AUC_inf of Raltegravir.**


<br>
<br>


<a id="figure-1-91"></a>

![](Sensitivity/Raltegravir_400mg__granules_in_suspension_-6_sensitivity_MRT.png)



**Figure 1-91: Most sensitive parameters for MRT of Raltegravir.**


<br>
<br>


<a id="figure-1-92"></a>

![](Sensitivity/Raltegravir_400mg__granules_in_suspension_-7_sensitivity_Thalf.png)



**Figure 1-92: Most sensitive parameters for Thalf of Raltegravir.**


<br>
<br>


<a id="figure-1-93"></a>

![](Sensitivity/Raltegravir_400mg__granules_in_suspension_-8_sensitivity_CL.png)



**Figure 1-93: Most sensitive parameters for CL of Raltegravir.**


<br>
<br>


<a id="figure-1-94"></a>

![](Sensitivity/Raltegravir_400mg__granules_in_suspension_-9_sensitivity_Vss.png)



**Figure 1-94: Most sensitive parameters for Vss of Raltegravir.**


<br>
<br>


<a id="figure-1-95"></a>

![](Sensitivity/Raltegravir_400mg__granules_in_suspension_-10_sensitivity_Vd.png)



**Figure 1-95: Most sensitive parameters for Vd of Raltegravir.**


<br>
<br>





# 2 PK parameters <a id="pk-parameters"></a>


## 2.1 PK parameters for Raltegravir 10 mg (lactose formulation) <a id="pk-parameters-raltegravir_10_mg__lactose_formulation_"></a>


<a id="table-2-1"></a>

**Table 2-1: PK parameters for Raltegravir 10 mg (lactose formulation)**


|Path        |Parameter    |Value   |Unit      |
|:-----------|:------------|:-------|:---------|
|Raltegravir |C_max        |110.49  |µg/l      |
|Raltegravir |C_max_norm   |0.81    |kg/l      |
|Raltegravir |t_max        |0.75    |h         |
|Raltegravir |C_tEnd       |1.96    |µg/l      |
|Raltegravir |AUC          |241.61  |µg*h/l    |
|Raltegravir |AUC_norm     |1.76    |kg*h/l    |
|Raltegravir |AUC_inf      |255.14  |µg*h/l    |
|Raltegravir |AUC_inf_norm |1.86    |kg*h/l    |
|Raltegravir |MRT          |3.33    |h         |
|Raltegravir |Thalf        |4.79    |h         |
|Raltegravir |CL           |8.95    |ml/min/kg |
|Raltegravir |Vss          |1787.57 |ml/kg     |
|Raltegravir |Vd           |3713.90 |ml/kg     |


<br>
<br>


## 2.2 PK parameters for Raltegravir 100 mg filmcoated tablet md <a id="pk-parameters-raltegravir_100_mg_filmcoated_tablet_md"></a>


<a id="table-2-2"></a>

**Table 2-2: PK parameters for Raltegravir 100 mg filmcoated tablet md**


|Path        |Parameter                    |Value   |Unit   |
|:-----------|:----------------------------|:-------|:------|
|Raltegravir |C_max                        |893.50  |µg/l   |
|Raltegravir |C_max_norm                   |0.03    |kg/l   |
|Raltegravir |C_max_t1_t2                  |863.16  |µg/l   |
|Raltegravir |C_max_t1_t2_norm             |0.63    |kg/l   |
|Raltegravir |C_max_tLast_tEnd             |892.65  |µg/l   |
|Raltegravir |C_max_tLast_tEnd_norm        |0.65    |kg/l   |
|Raltegravir |t_max                        |168.75  |h      |
|Raltegravir |t_max_t1_t2                  |0.75    |h      |
|Raltegravir |t_max_tLast_tEnd             |228.75  |h      |
|Raltegravir |C_trough_t2                  |19.66   |µg/l   |
|Raltegravir |C_trough_tLast               |31.92   |µg/l   |
|Raltegravir |AUC_t1_t2                    |1978.76 |µg*h/l |
|Raltegravir |AUC_t1_t2_norm               |1.44    |kg*h/l |
|Raltegravir |AUC_tLast_minus_1_tLast      |2218.73 |µg*h/l |
|Raltegravir |AUC_tLast_minus_1_tLast_norm |1.62    |kg*h/l |
|Raltegravir |AUC_inf_t1                   |2144.35 |µg*h/l |
|Raltegravir |AUC_inf_t1_norm              |1.57    |kg*h/l |
|Raltegravir |AUC_inf_tLast                |2536.55 |µg*h/l |
|Raltegravir |AUC_inf_tLast_norm           |1.85    |kg*h/l |
|Raltegravir |MRT                          |3.96    |h      |
|Raltegravir |Thalf                        |5.84    |h      |
|Raltegravir |Thalf_tLast_tEnd             |6.90    |h      |


<br>
<br>


## 2.3 PK parameters for Raltegravir 200 mg filmcoated tablet md <a id="pk-parameters-raltegravir_200_mg_filmcoated_tablet_md"></a>


<a id="table-2-3"></a>

**Table 2-3: PK parameters for Raltegravir 200 mg filmcoated tablet md**


|Path        |Parameter                    |Value   |Unit   |
|:-----------|:----------------------------|:-------|:------|
|Raltegravir |C_max                        |1811.96 |µg/l   |
|Raltegravir |C_max_norm                   |0.03    |kg/l   |
|Raltegravir |C_max_t1_t2                  |1748.66 |µg/l   |
|Raltegravir |C_max_t1_t2_norm             |0.64    |kg/l   |
|Raltegravir |C_max_tLast_tEnd             |1808.60 |µg/l   |
|Raltegravir |C_max_tLast_tEnd_norm        |0.66    |kg/l   |
|Raltegravir |t_max                        |204.75  |h      |
|Raltegravir |t_max_t1_t2                  |0.75    |h      |
|Raltegravir |t_max_tLast_tEnd             |228.75  |h      |
|Raltegravir |C_trough_t2                  |39.47   |µg/l   |
|Raltegravir |C_trough_tLast               |64.03   |µg/l   |
|Raltegravir |AUC_t1_t2                    |3998.12 |µg*h/l |
|Raltegravir |AUC_t1_t2_norm               |1.46    |kg*h/l |
|Raltegravir |AUC_tLast_minus_1_tLast      |4480.74 |µg*h/l |
|Raltegravir |AUC_tLast_minus_1_tLast_norm |1.64    |kg*h/l |
|Raltegravir |AUC_inf_t1                   |4329.13 |µg*h/l |
|Raltegravir |AUC_inf_t1_norm              |1.58    |kg*h/l |
|Raltegravir |AUC_inf_tLast                |5115.69 |µg*h/l |
|Raltegravir |AUC_inf_tLast_norm           |1.87    |kg*h/l |
|Raltegravir |MRT                          |3.94    |h      |
|Raltegravir |Thalf                        |5.81    |h      |
|Raltegravir |Thalf_tLast_tEnd             |6.87    |h      |


<br>
<br>


## 2.4 PK parameters for Filmcoated_tablet_400mg_sd <a id="pk-parameters-filmcoated_tablet_400mg_sd"></a>


<a id="table-2-4"></a>

**Table 2-4: PK parameters for Filmcoated_tablet_400mg_sd**


|Path        |Parameter    |Value   |Unit      |
|:-----------|:------------|:-------|:---------|
|Raltegravir |C_max        |3568.56 |µg/l      |
|Raltegravir |C_max_norm   |0.65    |kg/l      |
|Raltegravir |t_max        |0.75    |h         |
|Raltegravir |C_tEnd       |28.27   |µg/l      |
|Raltegravir |AUC          |8703.65 |µg*h/l    |
|Raltegravir |AUC_norm     |1.59    |kg*h/l    |
|Raltegravir |AUC_inf      |9072.43 |µg*h/l    |
|Raltegravir |AUC_inf_norm |1.66    |kg*h/l    |
|Raltegravir |MRT          |4.89    |h         |
|Raltegravir |Thalf        |9.04    |h         |
|Raltegravir |CL           |10.07   |ml/min/kg |
|Raltegravir |Vss          |2954.74 |ml/kg     |
|Raltegravir |Vd           |7878.98 |ml/kg     |


<br>
<br>


## 2.5 PK parameters for Raltegravir 400 mg filmcoated tablet md <a id="pk-parameters-raltegravir_400_mg_filmcoated_tablet_md"></a>


<a id="table-2-5"></a>

**Table 2-5: PK parameters for Raltegravir 400 mg filmcoated tablet md**


|Path        |Parameter                    |Value    |Unit   |
|:-----------|:----------------------------|:--------|:------|
|Raltegravir |C_max                        |3691.84  |µg/l   |
|Raltegravir |C_max_norm                   |0.03     |kg/l   |
|Raltegravir |C_max_t1_t2                  |3569.01  |µg/l   |
|Raltegravir |C_max_t1_t2_norm             |0.65     |kg/l   |
|Raltegravir |C_max_tLast_tEnd             |3689.99  |µg/l   |
|Raltegravir |C_max_tLast_tEnd_norm        |0.67     |kg/l   |
|Raltegravir |t_max                        |72.75    |h      |
|Raltegravir |t_max_t1_t2                  |0.75     |h      |
|Raltegravir |t_max_tLast_tEnd             |228.75   |h      |
|Raltegravir |C_trough_t2                  |79.75    |µg/l   |
|Raltegravir |C_trough_tLast               |129.19   |µg/l   |
|Raltegravir |AUC_t1_t2                    |8128.05  |µg*h/l |
|Raltegravir |AUC_t1_t2_norm               |1.48     |kg*h/l |
|Raltegravir |AUC_tLast_minus_1_tLast      |9098.53  |µg*h/l |
|Raltegravir |AUC_tLast_minus_1_tLast_norm |1.66     |kg*h/l |
|Raltegravir |AUC_inf_t1                   |8798.72  |µg*h/l |
|Raltegravir |AUC_inf_t1_norm              |1.61     |kg*h/l |
|Raltegravir |AUC_inf_tLast                |10365.92 |µg*h/l |
|Raltegravir |AUC_inf_tLast_norm           |1.89     |kg*h/l |
|Raltegravir |MRT                          |3.93     |h      |
|Raltegravir |Thalf                        |5.83     |h      |
|Raltegravir |Thalf_tLast_tEnd             |6.80     |h      |


<br>
<br>


## 2.6 PK parameters for Raltegravir 400mg chewable fasted <a id="pk-parameters-raltegravir_400mg_chewable_fasted"></a>


<a id="table-2-6"></a>

**Table 2-6: PK parameters for Raltegravir 400mg chewable fasted**


|Path        |Parameter    |Value    |Unit      |
|:-----------|:------------|:--------|:---------|
|Raltegravir |C_max        |6330.52  |µg/l      |
|Raltegravir |C_max_norm   |1.16     |kg/l      |
|Raltegravir |t_max        |0.75     |h         |
|Raltegravir |C_tEnd       |35.84    |µg/l      |
|Raltegravir |AUC          |14694.82 |µg*h/l    |
|Raltegravir |AUC_norm     |2.68     |kg*h/l    |
|Raltegravir |AUC_inf      |15124.21 |µg*h/l    |
|Raltegravir |AUC_inf_norm |2.76     |kg*h/l    |
|Raltegravir |MRT          |4.19     |h         |
|Raltegravir |Thalf        |8.31     |h         |
|Raltegravir |CL           |6.04     |ml/min/kg |
|Raltegravir |Vss          |1516.69  |ml/kg     |
|Raltegravir |Vd           |4340.96  |ml/kg     |


<br>
<br>


## 2.7 PK parameters for Raltegravir 400mg chewable fed <a id="pk-parameters-raltegravir_400mg_chewable_fed"></a>


<a id="table-2-7"></a>

**Table 2-7: PK parameters for Raltegravir 400mg chewable fed**


|Path        |Parameter    |Value    |Unit      |
|:-----------|:------------|:--------|:---------|
|Raltegravir |C_max        |2580.44  |µg/l      |
|Raltegravir |C_max_norm   |0.47     |kg/l      |
|Raltegravir |t_max        |2.50     |h         |
|Raltegravir |C_tEnd       |35.93    |µg/l      |
|Raltegravir |AUC          |14119.09 |µg*h/l    |
|Raltegravir |AUC_norm     |2.58     |kg*h/l    |
|Raltegravir |AUC_inf      |14606.36 |µg*h/l    |
|Raltegravir |AUC_inf_norm |2.67     |kg*h/l    |
|Raltegravir |MRT          |5.99     |h         |
|Raltegravir |Thalf        |9.40     |h         |
|Raltegravir |CL           |6.25     |ml/min/kg |
|Raltegravir |Vss          |2246.85  |ml/kg     |
|Raltegravir |Vd           |5087.80  |ml/kg     |


<br>
<br>


## 2.8 PK parameters for Raltegravir 400mg (granules in suspension) <a id="pk-parameters-raltegravir_400mg__granules_in_suspension_"></a>


<a id="table-2-8"></a>

**Table 2-8: PK parameters for Raltegravir 400mg (granules in suspension)**


|Path        |Parameter    |Value    |Unit      |
|:-----------|:------------|:--------|:---------|
|Raltegravir |C_max        |8156.79  |µg/l      |
|Raltegravir |C_max_norm   |1.49     |kg/l      |
|Raltegravir |t_max        |0.70     |h         |
|Raltegravir |C_tEnd       |42.19    |µg/l      |
|Raltegravir |AUC          |18791.01 |µg*h/l    |
|Raltegravir |AUC_norm     |3.43     |kg*h/l    |
|Raltegravir |AUC_inf      |19278.71 |µg*h/l    |
|Raltegravir |AUC_inf_norm |3.52     |kg*h/l    |
|Raltegravir |MRT          |4.02     |h         |
|Raltegravir |Thalf        |8.01     |h         |
|Raltegravir |CL           |4.74     |ml/min/kg |
|Raltegravir |Vss          |1142.66  |ml/kg     |
|Raltegravir |Vd           |3285.73  |ml/kg     |


<br>
<br>





# 3 Absorption <a id="absorption"></a>


## 3.1 Absorption for Raltegravir 10 mg (lactose formulation) <a id="absorption-raltegravir_10_mg__lactose_formulation_"></a>


<a id="figure-3-1"></a>

![](Absorption/Raltegravir_10_mg__lactose_formulation_-1_absorption_Raltegravir.png)



**Figure 3-1: Absorption of Raltegravir**


<br>
<br>


## 3.2 Absorption for Raltegravir 100 mg filmcoated tablet md <a id="absorption-raltegravir_100_mg_filmcoated_tablet_md"></a>


<a id="figure-3-2"></a>

![](Absorption/Raltegravir_100_mg_filmcoated_tablet_md-1_absorption_Raltegravir.png)



**Figure 3-2: Absorption of Raltegravir**


<br>
<br>


## 3.3 Absorption for Raltegravir 200 mg filmcoated tablet md <a id="absorption-raltegravir_200_mg_filmcoated_tablet_md"></a>


<a id="figure-3-3"></a>

![](Absorption/Raltegravir_200_mg_filmcoated_tablet_md-1_absorption_Raltegravir.png)



**Figure 3-3: Absorption of Raltegravir**


<br>
<br>


## 3.4 Absorption for Filmcoated_tablet_400mg_sd <a id="absorption-filmcoated_tablet_400mg_sd"></a>


<a id="figure-3-4"></a>

![](Absorption/Filmcoated_tablet_400mg_sd-1_absorption_Raltegravir.png)



**Figure 3-4: Absorption of Raltegravir**


<br>
<br>


## 3.5 Absorption for Raltegravir 400 mg filmcoated tablet md <a id="absorption-raltegravir_400_mg_filmcoated_tablet_md"></a>


<a id="figure-3-5"></a>

![](Absorption/Raltegravir_400_mg_filmcoated_tablet_md-1_absorption_Raltegravir.png)



**Figure 3-5: Absorption of Raltegravir**


<br>
<br>


## 3.6 Absorption for Raltegravir 400mg chewable fasted <a id="absorption-raltegravir_400mg_chewable_fasted"></a>


<a id="figure-3-6"></a>

![](Absorption/Raltegravir_400mg_chewable_fasted-1_absorption_Raltegravir.png)



**Figure 3-6: Absorption of Raltegravir**


<br>
<br>


## 3.7 Absorption for Raltegravir 400mg chewable fed <a id="absorption-raltegravir_400mg_chewable_fed"></a>


<a id="figure-3-7"></a>

![](Absorption/Raltegravir_400mg_chewable_fed-1_absorption_Raltegravir.png)



**Figure 3-7: Absorption of Raltegravir**


<br>
<br>


## 3.8 Absorption for Raltegravir 400mg (granules in suspension) <a id="absorption-raltegravir_400mg__granules_in_suspension_"></a>


<a id="figure-3-8"></a>

![](Absorption/Raltegravir_400mg__granules_in_suspension_-1_absorption_Raltegravir.png)



**Figure 3-8: Absorption of Raltegravir**


<br>
<br>





# 4 Mass Balance <a id="mass-balance"></a>


## 4.1 Mass Balance for Raltegravir 10 mg (lactose formulation) <a id="mass-balance-raltegravir_10_mg__lactose_formulation_"></a>


### 4.1.1 Mass Balance for Raltegravir <a id="1_mass_balance"></a>


<a id="figure-4-1"></a>

![](MassBalance/Raltegravir_10_mg__lactose_formulation_-2_mass_balance_Raltegravir_10_mg__lactose_formulation_.png)



**Figure 4-1: Amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-2"></a>

![](MassBalance/Raltegravir_10_mg__lactose_formulation_-3_mass_balance_Raltegravir_10_mg__lactose_formulation_.png)



**Figure 4-2: Cumulated amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-3"></a>

![](MassBalance/Raltegravir_10_mg__lactose_formulation_-4_mass_balance_Raltegravir_10_mg__lactose_formulation_.png)



**Figure 4-3: Amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-4"></a>

![](MassBalance/Raltegravir_10_mg__lactose_formulation_-5_mass_balance_Raltegravir_10_mg__lactose_formulation_.png)



**Figure 4-4: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-5"></a>

![](MassBalance/Raltegravir_10_mg__lactose_formulation_-6_mass_balance_Raltegravir_10_mg__lactose_formulation_.png)



**Figure 4-5: Fraction of drug within the different compartments at 12.00h for Raltegravir**


<br>
<br>


## 4.2 Mass Balance for Raltegravir 100 mg filmcoated tablet md <a id="mass-balance-raltegravir_100_mg_filmcoated_tablet_md"></a>


### 4.2.1 Mass Balance for Raltegravir <a id="1_mass_balance"></a>


<a id="figure-4-6"></a>

![](MassBalance/Raltegravir_100_mg_filmcoated_tablet_md-2_mass_balance_Raltegravir_100_mg_filmcoated_tablet_md.png)



**Figure 4-6: Amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-7"></a>

![](MassBalance/Raltegravir_100_mg_filmcoated_tablet_md-3_mass_balance_Raltegravir_100_mg_filmcoated_tablet_md.png)



**Figure 4-7: Cumulated amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-8"></a>

![](MassBalance/Raltegravir_100_mg_filmcoated_tablet_md-4_mass_balance_Raltegravir_100_mg_filmcoated_tablet_md.png)



**Figure 4-8: Amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-9"></a>

![](MassBalance/Raltegravir_100_mg_filmcoated_tablet_md-5_mass_balance_Raltegravir_100_mg_filmcoated_tablet_md.png)



**Figure 4-9: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-10"></a>

![](MassBalance/Raltegravir_100_mg_filmcoated_tablet_md-6_mass_balance_Raltegravir_100_mg_filmcoated_tablet_md.png)



**Figure 4-10: Fraction of drug within the different compartments at 240.00h for Raltegravir**


<br>
<br>


## 4.3 Mass Balance for Raltegravir 200 mg filmcoated tablet md <a id="mass-balance-raltegravir_200_mg_filmcoated_tablet_md"></a>


### 4.3.1 Mass Balance for Raltegravir <a id="1_mass_balance"></a>


<a id="figure-4-11"></a>

![](MassBalance/Raltegravir_200_mg_filmcoated_tablet_md-2_mass_balance_Raltegravir_200_mg_filmcoated_tablet_md.png)



**Figure 4-11: Amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-12"></a>

![](MassBalance/Raltegravir_200_mg_filmcoated_tablet_md-3_mass_balance_Raltegravir_200_mg_filmcoated_tablet_md.png)



**Figure 4-12: Cumulated amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-13"></a>

![](MassBalance/Raltegravir_200_mg_filmcoated_tablet_md-4_mass_balance_Raltegravir_200_mg_filmcoated_tablet_md.png)



**Figure 4-13: Amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-14"></a>

![](MassBalance/Raltegravir_200_mg_filmcoated_tablet_md-5_mass_balance_Raltegravir_200_mg_filmcoated_tablet_md.png)



**Figure 4-14: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-15"></a>

![](MassBalance/Raltegravir_200_mg_filmcoated_tablet_md-6_mass_balance_Raltegravir_200_mg_filmcoated_tablet_md.png)



**Figure 4-15: Fraction of drug within the different compartments at 240.00h for Raltegravir**


<br>
<br>


## 4.4 Mass Balance for Filmcoated_tablet_400mg_sd <a id="mass-balance-filmcoated_tablet_400mg_sd"></a>


### 4.4.1 Mass Balance for Raltegravir <a id="1_mass_balance"></a>


<a id="figure-4-16"></a>

![](MassBalance/Filmcoated_tablet_400mg_sd-2_mass_balance_Filmcoated_tablet_400mg_sd.png)



**Figure 4-16: Amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-17"></a>

![](MassBalance/Filmcoated_tablet_400mg_sd-3_mass_balance_Filmcoated_tablet_400mg_sd.png)



**Figure 4-17: Cumulated amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-18"></a>

![](MassBalance/Filmcoated_tablet_400mg_sd-4_mass_balance_Filmcoated_tablet_400mg_sd.png)



**Figure 4-18: Amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-19"></a>

![](MassBalance/Filmcoated_tablet_400mg_sd-5_mass_balance_Filmcoated_tablet_400mg_sd.png)



**Figure 4-19: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-20"></a>

![](MassBalance/Filmcoated_tablet_400mg_sd-6_mass_balance_Filmcoated_tablet_400mg_sd.png)



**Figure 4-20: Fraction of drug within the different compartments at 24.00h for Raltegravir**


<br>
<br>


## 4.5 Mass Balance for Raltegravir 400 mg filmcoated tablet md <a id="mass-balance-raltegravir_400_mg_filmcoated_tablet_md"></a>


### 4.5.1 Mass Balance for Raltegravir <a id="1_mass_balance"></a>


<a id="figure-4-21"></a>

![](MassBalance/Raltegravir_400_mg_filmcoated_tablet_md-2_mass_balance_Raltegravir_400_mg_filmcoated_tablet_md.png)



**Figure 4-21: Amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-22"></a>

![](MassBalance/Raltegravir_400_mg_filmcoated_tablet_md-3_mass_balance_Raltegravir_400_mg_filmcoated_tablet_md.png)



**Figure 4-22: Cumulated amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-23"></a>

![](MassBalance/Raltegravir_400_mg_filmcoated_tablet_md-4_mass_balance_Raltegravir_400_mg_filmcoated_tablet_md.png)



**Figure 4-23: Amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-24"></a>

![](MassBalance/Raltegravir_400_mg_filmcoated_tablet_md-5_mass_balance_Raltegravir_400_mg_filmcoated_tablet_md.png)



**Figure 4-24: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-25"></a>

![](MassBalance/Raltegravir_400_mg_filmcoated_tablet_md-6_mass_balance_Raltegravir_400_mg_filmcoated_tablet_md.png)



**Figure 4-25: Fraction of drug within the different compartments at 240.00h for Raltegravir**


<br>
<br>


## 4.6 Mass Balance for Raltegravir 400mg chewable fasted <a id="mass-balance-raltegravir_400mg_chewable_fasted"></a>


### 4.6.1 Mass Balance for Raltegravir <a id="1_mass_balance"></a>


<a id="figure-4-26"></a>

![](MassBalance/Raltegravir_400mg_chewable_fasted-2_mass_balance_Raltegravir_400mg_chewable_fasted.png)



**Figure 4-26: Amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-27"></a>

![](MassBalance/Raltegravir_400mg_chewable_fasted-3_mass_balance_Raltegravir_400mg_chewable_fasted.png)



**Figure 4-27: Cumulated amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-28"></a>

![](MassBalance/Raltegravir_400mg_chewable_fasted-4_mass_balance_Raltegravir_400mg_chewable_fasted.png)



**Figure 4-28: Amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-29"></a>

![](MassBalance/Raltegravir_400mg_chewable_fasted-5_mass_balance_Raltegravir_400mg_chewable_fasted.png)



**Figure 4-29: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-30"></a>

![](MassBalance/Raltegravir_400mg_chewable_fasted-6_mass_balance_Raltegravir_400mg_chewable_fasted.png)



**Figure 4-30: Fraction of drug within the different compartments at 24.00h for Raltegravir**


<br>
<br>


## 4.7 Mass Balance for Raltegravir 400mg chewable fed <a id="mass-balance-raltegravir_400mg_chewable_fed"></a>


### 4.7.1 Mass Balance for Raltegravir <a id="1_mass_balance"></a>


<a id="figure-4-31"></a>

![](MassBalance/Raltegravir_400mg_chewable_fed-2_mass_balance_Raltegravir_400mg_chewable_fed.png)



**Figure 4-31: Amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-32"></a>

![](MassBalance/Raltegravir_400mg_chewable_fed-3_mass_balance_Raltegravir_400mg_chewable_fed.png)



**Figure 4-32: Cumulated amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-33"></a>

![](MassBalance/Raltegravir_400mg_chewable_fed-4_mass_balance_Raltegravir_400mg_chewable_fed.png)



**Figure 4-33: Amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-34"></a>

![](MassBalance/Raltegravir_400mg_chewable_fed-5_mass_balance_Raltegravir_400mg_chewable_fed.png)



**Figure 4-34: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-35"></a>

![](MassBalance/Raltegravir_400mg_chewable_fed-6_mass_balance_Raltegravir_400mg_chewable_fed.png)



**Figure 4-35: Fraction of drug within the different compartments at 24.00h for Raltegravir**


<br>
<br>


## 4.8 Mass Balance for Raltegravir 400mg (granules in suspension) <a id="mass-balance-raltegravir_400mg__granules_in_suspension_"></a>


### 4.8.1 Mass Balance for Raltegravir <a id="1_mass_balance"></a>


<a id="figure-4-36"></a>

![](MassBalance/Raltegravir_400mg__granules_in_suspension_-2_mass_balance_Raltegravir_400mg__granules_in_suspension_.png)



**Figure 4-36: Amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-37"></a>

![](MassBalance/Raltegravir_400mg__granules_in_suspension_-3_mass_balance_Raltegravir_400mg__granules_in_suspension_.png)



**Figure 4-37: Cumulated amount of drug vs time within the different compartments for Raltegravir**


<br>
<br>


<a id="figure-4-38"></a>

![](MassBalance/Raltegravir_400mg__granules_in_suspension_-4_mass_balance_Raltegravir_400mg__granules_in_suspension_.png)



**Figure 4-38: Amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-39"></a>

![](MassBalance/Raltegravir_400mg__granules_in_suspension_-5_mass_balance_Raltegravir_400mg__granules_in_suspension_.png)



**Figure 4-39: Cumulated amount of drug vs time within the different compartments normalized to applicated drugmass for Raltegravir**


<br>
<br>


<a id="figure-4-40"></a>

![](MassBalance/Raltegravir_400mg__granules_in_suspension_-6_mass_balance_Raltegravir_400mg__granules_in_suspension_.png)



**Figure 4-40: Fraction of drug within the different compartments at 24.00h for Raltegravir**


<br>
<br>





# 5 Time profiles and residual plots <a id="time-profiles"></a>


## 5.1 Time profiles and residual plots for Raltegravir 10 mg (lactose formulation) <a id="time-profiles-raltegravir_10_mg__lactose_formulation_"></a>


<a id="figure-5-1"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-3_timeProfile_Concentration_total.png)



**Figure 5-1: Time profiles for Raltegravir 10 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-2"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-4_timeProfileLog_Concentration_total.png)



**Figure 5-2: Time profiles for Raltegravir 10 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-3"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-5_obsVsPred_Concentration_total.png)



**Figure 5-3: Predicted vs observed for Raltegravir 10 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-4"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-6_obsVsPredLog_Concentration_total.png)



**Figure 5-4: Predicted vs observed for Raltegravir 10 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-5"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-7_resVsPred_total.png)



**Figure 5-5: Logarithmic residuals vs predicted values for Raltegravir 10 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-6"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-8_resVsTime_total.png)



**Figure 5-6: Logarithmic residuals vs time values for Raltegravir 10 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-7"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-9_resHisto_total.png)



**Figure 5-7: Logarithmic residuals distribution (stacked) for Raltegravir 10 mg (lactose formulation). Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-8"></a>

![](TimeProfiles/Raltegravir_10_mg__lactose_formulation_-10_resQQPlot_total.png)



**Figure 5-8: Logarithmic residuals for Raltegravir 10 mg (lactose formulation) as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


## 5.2 Time profiles and residual plots for Raltegravir 100 mg filmcoated tablet md <a id="time-profiles-raltegravir_100_mg_filmcoated_tablet_md"></a>


### 5.2.1 For total simulation time range <a id="goodness-of-fit-raltegravir_100_mg_filmcoated_tablet_md-total"></a>


<a id="figure-5-9"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-4_timeProfile_Concentration_total.png)



**Figure 5-9: Time profiles for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-10"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-5_timeProfileLog_Concentration_total.png)



**Figure 5-10: Time profiles for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-11"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-6_obsVsPred_Concentration_total.png)



**Figure 5-11: Predicted vs observed for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-12"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-7_obsVsPredLog_Concentration_total.png)



**Figure 5-12: Predicted vs observed for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-13"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-8_resVsPred_total.png)



**Figure 5-13: Logarithmic residuals vs predicted values for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-14"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-9_resVsTime_total.png)



**Figure 5-14: Logarithmic residuals vs time values for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-15"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-10_resHisto_total.png)



**Figure 5-15: Logarithmic residuals distribution (stacked) for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-16"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-11_resQQPlot_total.png)



**Figure 5-16: Logarithmic residuals for Raltegravir 100 mg filmcoated tablet md as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


### 5.2.2 For first application range <a id="goodness-of-fit-raltegravir_100_mg_filmcoated_tablet_md-first"></a>


<a id="figure-5-17"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-13_timeProfile_Concentration_firstApplication.png)



**Figure 5-17: Time profiles for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-18"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-14_timeProfileLog_Concentration_firstApplication.png)



**Figure 5-18: Time profiles for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


### 5.2.3 For last application range <a id="goodness-of-fit-raltegravir_100_mg_filmcoated_tablet_md-last"></a>


<a id="figure-5-19"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-16_timeProfile_Concentration_lastApplication.png)



**Figure 5-19: Time profiles for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-20"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-17_timeProfileLog_Concentration_lastApplication.png)



**Figure 5-20: Time profiles for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-21"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-18_obsVsPred_Concentration_lastApplication.png)



**Figure 5-21: Predicted vs observed for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-22"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-19_obsVsPredLog_Concentration_lastApplication.png)



**Figure 5-22: Predicted vs observed for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-23"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-20_resVsPred_lastApplication.png)



**Figure 5-23: Logarithmic residuals vs predicted values for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-24"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-21_resVsTime_lastApplication.png)



**Figure 5-24: Logarithmic residuals vs time values for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-25"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-22_resHisto_lastApplication.png)



**Figure 5-25: Logarithmic residuals distribution (stacked) for Raltegravir 100 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-26"></a>

![](TimeProfiles/Raltegravir_100_mg_filmcoated_tablet_md-23_resQQPlot_lastApplication.png)



**Figure 5-26: Logarithmic residuals for Raltegravir 100 mg filmcoated tablet md as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


## 5.3 Time profiles and residual plots for Raltegravir 200 mg filmcoated tablet md <a id="time-profiles-raltegravir_200_mg_filmcoated_tablet_md"></a>


### 5.3.1 For total simulation time range <a id="goodness-of-fit-raltegravir_200_mg_filmcoated_tablet_md-total"></a>


<a id="figure-5-27"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-4_timeProfile_Concentration_total.png)



**Figure 5-27: Time profiles for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-28"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-5_timeProfileLog_Concentration_total.png)



**Figure 5-28: Time profiles for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-29"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-6_obsVsPred_Concentration_total.png)



**Figure 5-29: Predicted vs observed for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-30"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-7_obsVsPredLog_Concentration_total.png)



**Figure 5-30: Predicted vs observed for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-31"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-8_resVsPred_total.png)



**Figure 5-31: Logarithmic residuals vs predicted values for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-32"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-9_resVsTime_total.png)



**Figure 5-32: Logarithmic residuals vs time values for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-33"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-10_resHisto_total.png)



**Figure 5-33: Logarithmic residuals distribution (stacked) for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-34"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-11_resQQPlot_total.png)



**Figure 5-34: Logarithmic residuals for Raltegravir 200 mg filmcoated tablet md as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


### 5.3.2 For first application range <a id="goodness-of-fit-raltegravir_200_mg_filmcoated_tablet_md-first"></a>


<a id="figure-5-35"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-13_timeProfile_Concentration_firstApplication.png)



**Figure 5-35: Time profiles for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-36"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-14_timeProfileLog_Concentration_firstApplication.png)



**Figure 5-36: Time profiles for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


### 5.3.3 For last application range <a id="goodness-of-fit-raltegravir_200_mg_filmcoated_tablet_md-last"></a>


<a id="figure-5-37"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-16_timeProfile_Concentration_lastApplication.png)



**Figure 5-37: Time profiles for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-38"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-17_timeProfileLog_Concentration_lastApplication.png)



**Figure 5-38: Time profiles for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-39"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-18_obsVsPred_Concentration_lastApplication.png)



**Figure 5-39: Predicted vs observed for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-40"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-19_obsVsPredLog_Concentration_lastApplication.png)



**Figure 5-40: Predicted vs observed for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-41"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-20_resVsPred_lastApplication.png)



**Figure 5-41: Logarithmic residuals vs predicted values for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-42"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-21_resVsTime_lastApplication.png)



**Figure 5-42: Logarithmic residuals vs time values for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-43"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-22_resHisto_lastApplication.png)



**Figure 5-43: Logarithmic residuals distribution (stacked) for Raltegravir 200 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-44"></a>

![](TimeProfiles/Raltegravir_200_mg_filmcoated_tablet_md-23_resQQPlot_lastApplication.png)



**Figure 5-44: Logarithmic residuals for Raltegravir 200 mg filmcoated tablet md as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


## 5.4 Time profiles and residual plots for Filmcoated_tablet_400mg_sd <a id="time-profiles-filmcoated_tablet_400mg_sd"></a>


<a id="figure-5-45"></a>

![](TimeProfiles/Filmcoated_tablet_400mg_sd-3_timeProfile_Concentration_total.png)



**Figure 5-45: Time profiles for Filmcoated_tablet_400mg_sd. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-46"></a>

![](TimeProfiles/Filmcoated_tablet_400mg_sd-4_timeProfileLog_Concentration_total.png)



**Figure 5-46: Time profiles for Filmcoated_tablet_400mg_sd. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-47"></a>

![](TimeProfiles/Filmcoated_tablet_400mg_sd-5_obsVsPred_Concentration_total.png)



**Figure 5-47: Predicted vs observed for Filmcoated_tablet_400mg_sd. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-48"></a>

![](TimeProfiles/Filmcoated_tablet_400mg_sd-6_obsVsPredLog_Concentration_total.png)



**Figure 5-48: Predicted vs observed for Filmcoated_tablet_400mg_sd. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-49"></a>

![](TimeProfiles/Filmcoated_tablet_400mg_sd-7_resVsPred_total.png)



**Figure 5-49: Logarithmic residuals vs predicted values for Filmcoated_tablet_400mg_sd. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-50"></a>

![](TimeProfiles/Filmcoated_tablet_400mg_sd-8_resVsTime_total.png)



**Figure 5-50: Logarithmic residuals vs time values for Filmcoated_tablet_400mg_sd. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-51"></a>

![](TimeProfiles/Filmcoated_tablet_400mg_sd-9_resHisto_total.png)



**Figure 5-51: Logarithmic residuals distribution (stacked) for Filmcoated_tablet_400mg_sd. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-52"></a>

![](TimeProfiles/Filmcoated_tablet_400mg_sd-10_resQQPlot_total.png)



**Figure 5-52: Logarithmic residuals for Filmcoated_tablet_400mg_sd as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


## 5.5 Time profiles and residual plots for Raltegravir 400 mg filmcoated tablet md <a id="time-profiles-raltegravir_400_mg_filmcoated_tablet_md"></a>


### 5.5.1 For total simulation time range <a id="goodness-of-fit-raltegravir_400_mg_filmcoated_tablet_md-total"></a>


<a id="figure-5-53"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-4_timeProfile_Concentration_total.png)



**Figure 5-53: Time profiles for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-54"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-5_timeProfileLog_Concentration_total.png)



**Figure 5-54: Time profiles for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-55"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-6_obsVsPred_Concentration_total.png)



**Figure 5-55: Predicted vs observed for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-56"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-7_obsVsPredLog_Concentration_total.png)



**Figure 5-56: Predicted vs observed for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-57"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-8_resVsPred_total.png)



**Figure 5-57: Logarithmic residuals vs predicted values for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-58"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-9_resVsTime_total.png)



**Figure 5-58: Logarithmic residuals vs time values for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-59"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-10_resHisto_total.png)



**Figure 5-59: Logarithmic residuals distribution (stacked) for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-60"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-11_resQQPlot_total.png)



**Figure 5-60: Logarithmic residuals for Raltegravir 400 mg filmcoated tablet md as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


### 5.5.2 For first application range <a id="goodness-of-fit-raltegravir_400_mg_filmcoated_tablet_md-first"></a>


<a id="figure-5-61"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-13_timeProfile_Concentration_firstApplication.png)



**Figure 5-61: Time profiles for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-62"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-14_timeProfileLog_Concentration_firstApplication.png)



**Figure 5-62: Time profiles for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


### 5.5.3 For last application range <a id="goodness-of-fit-raltegravir_400_mg_filmcoated_tablet_md-last"></a>


<a id="figure-5-63"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-16_timeProfile_Concentration_lastApplication.png)



**Figure 5-63: Time profiles for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-64"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-17_timeProfileLog_Concentration_lastApplication.png)



**Figure 5-64: Time profiles for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-65"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-18_obsVsPred_Concentration_lastApplication.png)



**Figure 5-65: Predicted vs observed for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-66"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-19_obsVsPredLog_Concentration_lastApplication.png)



**Figure 5-66: Predicted vs observed for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-67"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-20_resVsPred_lastApplication.png)



**Figure 5-67: Logarithmic residuals vs predicted values for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-68"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-21_resVsTime_lastApplication.png)



**Figure 5-68: Logarithmic residuals vs time values for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-69"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-22_resHisto_lastApplication.png)



**Figure 5-69: Logarithmic residuals distribution (stacked) for Raltegravir 400 mg filmcoated tablet md. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-70"></a>

![](TimeProfiles/Raltegravir_400_mg_filmcoated_tablet_md-23_resQQPlot_lastApplication.png)



**Figure 5-70: Logarithmic residuals for Raltegravir 400 mg filmcoated tablet md as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


## 5.6 Time profiles and residual plots for Raltegravir 400mg chewable fasted <a id="time-profiles-raltegravir_400mg_chewable_fasted"></a>


<a id="figure-5-71"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fasted-3_timeProfile_Concentration_total.png)



**Figure 5-71: Time profiles for Raltegravir 400mg chewable fasted. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-72"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fasted-4_timeProfileLog_Concentration_total.png)



**Figure 5-72: Time profiles for Raltegravir 400mg chewable fasted. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-73"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fasted-5_obsVsPred_Concentration_total.png)



**Figure 5-73: Predicted vs observed for Raltegravir 400mg chewable fasted. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-74"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fasted-6_obsVsPredLog_Concentration_total.png)



**Figure 5-74: Predicted vs observed for Raltegravir 400mg chewable fasted. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-75"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fasted-7_resVsPred_total.png)



**Figure 5-75: Logarithmic residuals vs predicted values for Raltegravir 400mg chewable fasted. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-76"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fasted-8_resVsTime_total.png)



**Figure 5-76: Logarithmic residuals vs time values for Raltegravir 400mg chewable fasted. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-77"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fasted-9_resHisto_total.png)



**Figure 5-77: Logarithmic residuals distribution (stacked) for Raltegravir 400mg chewable fasted. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-78"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fasted-10_resQQPlot_total.png)



**Figure 5-78: Logarithmic residuals for Raltegravir 400mg chewable fasted as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


## 5.7 Time profiles and residual plots for Raltegravir 400mg chewable fed <a id="time-profiles-raltegravir_400mg_chewable_fed"></a>


<a id="figure-5-79"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fed-3_timeProfile_Concentration_total.png)



**Figure 5-79: Time profiles for Raltegravir 400mg chewable fed. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-80"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fed-4_timeProfileLog_Concentration_total.png)



**Figure 5-80: Time profiles for Raltegravir 400mg chewable fed. Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-81"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fed-5_obsVsPred_Concentration_total.png)



**Figure 5-81: Predicted vs observed for Raltegravir 400mg chewable fed. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-82"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fed-6_obsVsPredLog_Concentration_total.png)



**Figure 5-82: Predicted vs observed for Raltegravir 400mg chewable fed. Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-83"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fed-7_resVsPred_total.png)



**Figure 5-83: Logarithmic residuals vs predicted values for Raltegravir 400mg chewable fed. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-84"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fed-8_resVsTime_total.png)



**Figure 5-84: Logarithmic residuals vs time values for Raltegravir 400mg chewable fed. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-85"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fed-9_resHisto_total.png)



**Figure 5-85: Logarithmic residuals distribution (stacked) for Raltegravir 400mg chewable fed. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-86"></a>

![](TimeProfiles/Raltegravir_400mg_chewable_fed-10_resQQPlot_total.png)



**Figure 5-86: Logarithmic residuals for Raltegravir 400mg chewable fed as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


## 5.8 Time profiles and residual plots for Raltegravir 400mg (granules in suspension) <a id="time-profiles-raltegravir_400mg__granules_in_suspension_"></a>


<a id="figure-5-87"></a>

![](TimeProfiles/Raltegravir_400mg__granules_in_suspension_-3_timeProfile_Concentration_total.png)



**Figure 5-87: Time profiles for Raltegravir 400mg (granules in suspension). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-88"></a>

![](TimeProfiles/Raltegravir_400mg__granules_in_suspension_-4_timeProfileLog_Concentration_total.png)



**Figure 5-88: Time profiles for Raltegravir 400mg (granules in suspension). Data source: Data/Raltegravir_PK.txt. Time profiles are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-89"></a>

![](TimeProfiles/Raltegravir_400mg__granules_in_suspension_-5_obsVsPred_Concentration_total.png)



**Figure 5-89: Predicted vs observed for Raltegravir 400mg (granules in suspension). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-90"></a>

![](TimeProfiles/Raltegravir_400mg__granules_in_suspension_-6_obsVsPredLog_Concentration_total.png)



**Figure 5-90: Predicted vs observed for Raltegravir 400mg (granules in suspension). Data source: Data/Raltegravir_PK.txt. Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-91"></a>

![](TimeProfiles/Raltegravir_400mg__granules_in_suspension_-7_resVsPred_total.png)



**Figure 5-91: Logarithmic residuals vs predicted values for Raltegravir 400mg (granules in suspension). Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-92"></a>

![](TimeProfiles/Raltegravir_400mg__granules_in_suspension_-8_resVsTime_total.png)



**Figure 5-92: Logarithmic residuals vs time values for Raltegravir 400mg (granules in suspension). Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-93"></a>

![](TimeProfiles/Raltegravir_400mg__granules_in_suspension_-9_resHisto_total.png)



**Figure 5-93: Logarithmic residuals distribution (stacked) for Raltegravir 400mg (granules in suspension). Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


<a id="figure-5-94"></a>

![](TimeProfiles/Raltegravir_400mg__granules_in_suspension_-10_resQQPlot_total.png)



**Figure 5-94: Logarithmic residuals for Raltegravir 400mg (granules in suspension) as quantile-quantile plot. Data source: Data/Raltegravir_PK.txt.**


<br>
<br>


## 5.9 Residuals across all simulations <a id="time-profiles-residuals-across-all-simulations"></a>


<a id="figure-5-95"></a>

![](TimeProfiles/residuals_across_all_simulations_1_obsVsPred_Organism_PeripheralVenousBlood_Raltegravir_Plasma__Peripheral_Venous_Blood_.png)



**Figure 5-95: Predicted vs observed for Raltegravir across Raltegravir 10 mg (lactose formulation), Raltegravir 100 mg filmcoated tablet md, Raltegravir 200 mg filmcoated tablet md, Filmcoated_tablet_400mg_sd, Raltegravir 400 mg filmcoated tablet md, Raltegravir 400mg chewable fasted, Raltegravir 400mg chewable fed, Raltegravir 400mg (granules in suspension). Predictions and observations are plotted in a linear scale.**


<br>
<br>


<a id="figure-5-96"></a>

![](TimeProfiles/residuals_across_all_simulations_2_obsVsPredLog_Organism_PeripheralVenousBlood_Raltegravir_Plasma__Peripheral_Venous_Blood_.png)



**Figure 5-96: Predicted vs observed for Raltegravir across Raltegravir 10 mg (lactose formulation), Raltegravir 100 mg filmcoated tablet md, Raltegravir 200 mg filmcoated tablet md, Filmcoated_tablet_400mg_sd, Raltegravir 400 mg filmcoated tablet md, Raltegravir 400mg chewable fasted, Raltegravir 400mg chewable fed, Raltegravir 400mg (granules in suspension). Predictions and observations are plotted in a logarithmic scale.**


<br>
<br>


<a id="figure-5-97"></a>

![](TimeProfiles/residuals_across_all_simulations_3_res_vs_pred.png)



**Figure 5-97: Logarithmic residuals vs predicted values for Raltegravir across Raltegravir 10 mg (lactose formulation), Raltegravir 100 mg filmcoated tablet md, Raltegravir 200 mg filmcoated tablet md, Filmcoated_tablet_400mg_sd, Raltegravir 400 mg filmcoated tablet md, Raltegravir 400mg chewable fasted, Raltegravir 400mg chewable fed, Raltegravir 400mg (granules in suspension).**


<br>
<br>


<a id="figure-5-98"></a>

![](TimeProfiles/residuals_across_all_simulations_4_res_vs_time.png)



**Figure 5-98: Logarithmic residuals vs time values for Raltegravir across Raltegravir 10 mg (lactose formulation), Raltegravir 100 mg filmcoated tablet md, Raltegravir 200 mg filmcoated tablet md, Filmcoated_tablet_400mg_sd, Raltegravir 400 mg filmcoated tablet md, Raltegravir 400mg chewable fasted, Raltegravir 400mg chewable fed, Raltegravir 400mg (granules in suspension).**


<br>
<br>


<a id="figure-5-99"></a>

![](TimeProfiles/residuals_across_all_simulations_5_histogram.png)



**Figure 5-99: Logarithmic residuals distribution (stacked) for Raltegravir across Raltegravir 10 mg (lactose formulation), Raltegravir 100 mg filmcoated tablet md, Raltegravir 200 mg filmcoated tablet md, Filmcoated_tablet_400mg_sd, Raltegravir 400 mg filmcoated tablet md, Raltegravir 400mg chewable fasted, Raltegravir 400mg chewable fed, Raltegravir 400mg (granules in suspension).**


<br>
<br>


<a id="figure-5-100"></a>

![](TimeProfiles/residuals_across_all_simulations_6_qq_plot.png)



**Figure 5-100: Logarithmic residuals for Raltegravir across Raltegravir 10 mg (lactose formulation), Raltegravir 100 mg filmcoated tablet md, Raltegravir 200 mg filmcoated tablet md, Filmcoated_tablet_400mg_sd, Raltegravir 400 mg filmcoated tablet md, Raltegravir 400mg chewable fasted, Raltegravir 400mg chewable fed, Raltegravir 400mg (granules in suspension) as quantile-quantile plot.**


<br>
<br>



